No benefit of plasma therapy in reducing COVID-19 mortality risk, says AIIMS trial interim analysis
Published
AIIMS Director Dr Randeep Guleria told PTI on Thursday no clear mortality benefit of convalescent plasma therapy was seen during a trial conducted among 30 COVID-19 patients
Full Article